The global bone densitometers market size was valued at USD 241.2 million in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030. The rising bone related disorders such as osteoporosis, increasing geriatric population and technological advancements are driving the market growth. The growing awareness among people about bone health and increasing government programs and health initiatives to educate patients is accelerating the bone densitometers market.
Increasing geriatric population is one of the key drivers of the market as they are more prone to osteoporosis. According to World Health Organization (WHO), by 2050, the world’s population of people aged 60 or above to reach 2.1 billion. Osteoporosis causes more than 8.9 million fractures annually. The major cause for osteoporosis is rising unhealthy lifestyle, physical inactivity, increasing smoking and alcohol consumption.
The technological advancement in bone testing such as portable and home based bone densitometers encourages patients in early detection and prevention from osteoporosis. Furthermore, the integration of healthcare with emerging technology such as Artificial Intelligence (AI) and digital detectors are increasing the demand for bone health treatment.
Axial bone densitometry dominated the market and accounted for a share of 52.1% in 2023. The increasing adoption rate can be attributed to the fulfillment of different requirements of clinicians by axial bone densitometers. These predominantly include central dual energy x-ray absorptiometry-based tools that are imperative to obtain accurate results in diagnostic procedures.
The Peripheral bone densitometry segment is expected to witness significant CAGR during the forecast period, owing to its lower cost, faster scan speed and portability. Peripheral densitometers are small and portable which allows them to use in various settings beyond hospitals.
Osteoporosis & osteopenia accounted for the largest market revenue share of 31.2% in 2023. Osteopenia is loss of bone mass or bone mineral density, and these are more common among women & people aged 60 and above. The growth can be attributed to increasing geriatric population and rising number of accidents.
Rheumatoid arthritis is expected to grow during the forecast period. The growth can be attributed to rising geriatric population and improved diagnostics techniques. Although there’s no cure for rheumatoid arthritis, but early diagnosis and treatment can improve long term outcomes of the disease. Advancements in medical techniques such as advanced X-rays and MRI scans and ongoing research in rheumatoid arthritis cure is accelerating the market growth.
The hospitals segment dominated the market in 2023. The presence of highly skilled healthcare professionals, increasing number of road accidents and advanced medical devices have led to the segment growth.
The specialty clinics segment is anticipated to witness a CAGR of 6.1% during the forecast period, owing to advancement in bone densitometers technologies and rising penetration of clinics.
North America bone densitometers market dominated the market in 2023 owing to increase healthcare expenditure, better medical infrastructure and advancements in medical technologies. The rising cases of osteoporosis in the region is accelerating the growth. Countries such as Mexico, U.S. and Canada are driving the growth. According to International Osteoporosis Foundation, over 2.3 million Canadians aged 40 and above were living with osteoporosis, and in U.S. one in four men over age 50 is expected to suffer from breaking of bones due to osteoporosis.
The U.S. bone densitometers market dominated the North America market in 2023 owing to the strong healthcare infrastructure and ongoing research and development in field of osteoporosis. Moreover, the country hosts some key players in the bone densitometers and have a robust technological support. Furthermore, the rising awareness among people and ongoing R&D is driving the market growth.
Europe bone densitometers market was identified as a lucrative region in 2023. The growth is driven by the increasing aging population. The ongoing technological advances in bone densitometers diagnostics and early adoption of innovative medical technologies along with the rising awareness among people about bone disorders are driving the region’s growth.
The UK bone densitometers market accounted for the largest revenue share in 2023. The rise in prevalence of chronic and bones disease has led to the demand for bone densitometers. According to National Health Service (NHS), a national healthcare of UK, osteoporosis affects 3 million people in UK annually.
The Germany bone densitometers market is expected to grow rapidly during the forecast period owing to increasing aging population and ongoing technological advancements in medical devices.
Asia Pacific bone densitometers market is anticipated to witness the fastest CAGR during the forecast period, owing to rising urbanization, increasing per capita income and increasing healthcare infrastructure in the region.
The China bone densitometers market held a substantial market share in 2023. The market is driven by bone related disorder and increasing geriatric population in the country. According to WHO, the country could witness over 402 million people aged above 60+/ 28% of the total population by 2040.
The bone densitometers market in India is expected to witness significant growth during the forecast period, owing to rising disposable income, adoption of advanced medical technologies and improvements in healthcare infrastructure.
Some of the key companies in the bone densitometers marketinclude GE Healthcare, Hologic, DMS Imaging and others. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other major companies.
The following are the leading companies in the bone densitometers market. These companies collectively hold the largest market share and dictate industry trends.
Report Attribute |
Details |
Market size value in 2024 |
USD 253.0 million |
Revenue forecast in 2030 |
USD 329.3 million |
Growth rate |
CAGR of 4.5% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Technology, application, end use, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, Kuwait. |
Key companies profiled |
GE Healthcare; Hologic Inc.; DMS Imaging; Swissray International, Inc.; Xingaoyi Medical Equipment Co. Ltd; Eurotec Medical Systems Srl; Trivitron Healthcare; Scanflex Healthcare AB; Medonica Co. Ltd; OsteoSys Corp; |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global bone densitometers market report based on technology, application, end use and region.
Technology Outlook (Revenue, USD Million, 2018 - 2030)
Axial bone densitometry
Dual energy X-ray absorptiometry (DEXA)
Quantitative computed tomography (QCT)
Peripheral bone densitometry
Single energy X-ray absorptiometry (SEXA)
Dual energy X-ray absorptiometry (pDEXA)
Radiographic absorptiometry (RA)
Quantitative ultrasound (QUS)
Peripheral quantitative computed tomography (pQCT)
Application Outlook (Revenue, USD Million, 2018 - 2030)
Osteoporosis and osteopenia diagnosis
Cystic fibrosis diagnosis
Chronic kidney diseases diagnosis
Rheumatoid arthritis diagnosis
Body composition measurement
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Specialty Clinics
Other End Use
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."